CTNNB1 and breast cancer: It is believed that beta-catenin activator CTNNB1 mutations, which induce disturbances in Wnt/beta-catenin functioning, lead to increased accumulation of beta-catenin in the nucleus and have a key function in the development of breast cancer [3,4].